Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis. (NCT05990894) | Clinical Trial Compass
CompletedNot Applicable
Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.
China170 participantsStarted 2020-07-01
Plain-language summary
The cohort study aims to evaluate the efficacy and safety of steroids combined with anticoagulant therapy compared to standard anticoagulant therapy in acute/subacute severe cerebral venous thrombosis.
Who can participate
Age range14 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Acute or subacute severe CVT, determined by the onset-to-admission time (≤ 15 days) or symptom aggravation-to-admission time (≤ 15 days) and MRI+MRV/MRBTI (MR Black-Blood Thrombus Imaging), or CT+CTV
Exclusion Criteria:
* younger than 14 yearsï¼›
* foreign nationalityï¼›
* receiving steroids before the onset of CVTï¼›
* patients with other serious diseasesï¼›
* Presenting with neurological deficits before the onset of CVTï¼›
* lack of baseline data before treatmentï¼›
* receiving steroids during hospitalization for other reasons but the dosage did not reach pulsed-therapy level
* brain herniation but refusing to undergo decompressive craniectomy, or pupillary light reflex did not recover after decompressive craniectomy